Challenges of Anti-Mesothelin CAR-T-Cell Therapy

SIMPLE SUMMARY: In recent years, chimeric antigen receptor (CAR)-T-cell therapy has achieved good results in hematological malignancies. Clinical trials on anti-MSLN CAR-T cells have shown that they have a high safety profile but limited efficacy. This article reviews the clinical research status, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Xuejia, Mao, Ling, Wu, Min, Liu, Jie, Yu, Shicang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000068/
https://www.ncbi.nlm.nih.gov/pubmed/36900151
http://dx.doi.org/10.3390/cancers15051357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000068/
https://www.ncbi.nlm.nih.gov/pubmed/36900151
http://dx.doi.org/10.3390/cancers15051357

Ejemplares similares